Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,816 | 703 | 99.9% |
| Education | $13.25 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,777 | 127 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,663 | 154 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,615 | 94 | $0 (2024) |
| Lilly USA, LLC | $1,311 | 111 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $582.59 | 39 | $0 (2024) |
| PFIZER INC. | $356.47 | 22 | $0 (2024) |
| ABBVIE INC. | $355.38 | 15 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $345.96 | 22 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $313.56 | 23 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $172.46 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,432 | 88 | AstraZeneca Pharmaceuticals LP ($265.68) |
| 2023 | $1,488 | 103 | GlaxoSmithKline, LLC. ($344.45) |
| 2022 | $1,394 | 93 | GlaxoSmithKline, LLC. ($387.28) |
| 2021 | $1,529 | 104 | Novo Nordisk Inc ($270.34) |
| 2020 | $1,102 | 76 | Novo Nordisk Inc ($293.47) |
| 2019 | $1,202 | 107 | Novo Nordisk Inc ($285.86) |
| 2018 | $1,436 | 116 | AstraZeneca Pharmaceuticals LP ($294.67) |
| 2017 | $247.33 | 18 | AstraZeneca Pharmaceuticals LP ($88.16) |
All Payment Transactions
705 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Biological | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Obesity | ||||||
| 10/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,284 | 1,710 | $185,669 | $84,636 |
| 2022 | 18 | 1,079 | 1,386 | $156,285 | $67,590 |
| 2021 | 16 | 765 | 1,081 | $118,864 | $49,463 |
| 2020 | 17 | 830 | 1,191 | $125,743 | $48,251 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 223 | 223 | $54,635 | $28,163 | 51.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 171 | 233 | $37,746 | $12,892 | 34.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 34 | 34 | $19,822 | $9,555 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 98 | $22,540 | $7,655 | 34.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 101 | 103 | $13,818 | $7,385 | 53.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 97 | $8,730 | $4,457 | 51.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 269 | 484 | $6,292 | $4,027 | 64.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 103 | 105 | $3,255 | $3,099 | 95.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 65 | 71 | $6,745 | $2,547 | 37.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,835 | $1,781 | 46.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 36 | 36 | $1,332 | $1,062 | 79.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 25 | $2,000 | $881.26 | 44.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 54 | 73 | $1,460 | $439.92 | 30.1% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 14 | 14 | $507.68 | $247.66 | 48.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 15 | 15 | $1,125 | $185.25 | 16.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 57 | 77 | $1,232 | $169.40 | 13.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $594.00 | $90.53 | 15.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 149 | 149 | $36,505 | $19,073 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 170 | 248 | $40,176 | $14,610 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 107 | $24,610 | $8,672 | 35.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 24 | 24 | $13,992 | $6,699 | 47.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 75 | 76 | $9,850 | $5,054 | 51.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 20 | 69 | $6,210 | $3,160 | 50.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 58 | 62 | $5,890 | $2,248 | 38.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 75 | 76 | $2,296 | $2,121 | 92.4% |
About Dr. Debra Hammond, MD
Dr. Debra Hammond, MD is a Family Medicine healthcare provider based in Amarillo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194789420.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Hammond, MD has received a total of $9,829 in payments from pharmaceutical and medical device companies, with $1,432 received in 2024. These payments were reported across 705 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($9,816).
As a Medicare-enrolled provider, Hammond has provided services to 3,958 Medicare beneficiaries, totaling 5,368 services with total Medicare billing of $249,941. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Amarillo, TX
- Active Since 04/13/2006
- Last Updated 07/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1194789420
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,333
- FARXIGA (Drug) $1,060
- Ozempic (Drug) $942.84
- TRULICITY (Drug) $500.82
- JARDIANCE (Drug) $491.74
- MOUNJARO (Drug) $373.81
- XARELTO (Drug) $282.86
- TRINTELLIX (Drug) $237.09
- VRAYLAR (Drug) $223.18
- SYMBICORT (Drug) $217.23
- Victoza (Drug) $193.87
- UBRELVY (Drug) $192.67
- EMGALITY (Drug) $182.87
- Wegovy (Drug) $179.83
- Saxenda (Drug) $170.60
- NURTEC ODT (Drug) $144.96
- PREVNAR 20 (Biological) $143.83
- BASAGLAR (Drug) $137.94
- BREZTRI (Drug) $113.66
- Tresiba (Drug) $112.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Amarillo
Sang Tae Kim, Do, DO
Family Medicine — Payments: $444,684
Dr. Ron Rankin, M.d, M.D
Family Medicine — Payments: $197,025
Dr. Cristiane Ennis, M.d, M.D
Family Medicine — Payments: $97,846
Evelyn Sbar, M.d, M.D
Family Medicine — Payments: $51,869
Dr. David Brister, M.d, M.D
Family Medicine — Payments: $12,372
Dr. Frederick Poage, D.o, D.O
Family Medicine — Payments: $11,752